Global CBD Hemp Oil Market By CBD Type (Full-spectrum CBD (Less than 0.3 Percent THC), Broad-spectrum CBD (THC-free), CBD Isolate); By Product Type (Tinctures, Drops, Spray, Others); By Type (Flavored, Unflavored/ Natural); By Strength (Less than 350 mg, 350 mg to 750 mg, 750 mg to 1500 mg, More than 1500 mg); By Medical Indication (Anxiety & Depression, Nausea, Digestive Disorder, Chronic Pain, Infection Prevention, Sleep Disorders, Others); By Application (Humans, Animals/ Pets); By Distribution Channel (Online, Offline – Retail Pharmacy, Hospital Pharmacy, Others); By Region (North America (U.S., Canada, Mexico, Rest Of North America), Europe (France, The UK, Spain, Germany, Italy, Denmark, Finland, Iceland, Sweden, Norway, Belgium, The Netherlands, Luxembourg, Rest of Europe), Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia, Rest of Asia Pacific, Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa) Latin America (Brazil, Argentina, Rest of Latin America)) - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2023 – 2031
Industry Trends
CBD hemp oil happens to be a type of oil that is derived from the hemp plant that contains high levels of cannabidiol (CBD). CBD is a non-intoxicating compound that is found in hemp and marijuana plants that has been associated with numerous potential health benefits. Hemp oil is made from the seeds of the hemp plant and contains little to no CBD. CBD hemp oil, on the other hand, is extracted from the flowers, leaves, and stalks of the hemp plant and contains significant levels of CBD. CBD hemp oil can be used as a dietary supplement and is commonly used for its potential health benefits, which may include reducing anxiety, promoting relaxation, relieving pain, and improving sleep quality. It is also used in various forms such as tinctures, capsules, topicals, and more. It's important to note that CBD hemp oil is not the same as marijuana oil or hemp seed oil, which have different properties and uses.
It is often marketed as a natural remedy for a variety of health concerns, and some people claim that it has multiple potential benefits. The potential benefits of CBD hemp oil consists of qualities related to pain relief, anxiety and depression and neuroprotective properties. Along with these, this oil also possesses pain-relieving properties, and it is likely to be useful for the management of chronic pain and inflammation. According to several studies, the CBD can help reduce symptoms of anxiety and depression, though more research is needed. Meanwhile, it also possesses neuroprotective properties, meaning that it is likely to aid in protecting the brain from damage and degeneration. In wake of multiple factors, the global CBD hemp oil market is growing rampantly.
In terms of revenue, the global CBD hemp oil market was valued at US$ 1.92 Bn in 2022, growing at a CAGR of 18.2% over the forecast period (2023 – 2031). The study analyses the market in terms of revenue across all the major regions, which have been bifurcated into countries.
CBD Type Outlook
Based on the CBD type outlook, the global CBD hemp oil market has been bifurcated into full-spectrum CBD (less than 0.3 percent THC), Broad-spectrum CBD (THC-free) and CBD isolate. Full-spectrum CBD normally contains many components of the cannabis plant that include trace amounts of tetrahydrocannabinol (THC). The full-spectrum products that are legal on federal level will always possess less than 0.3 percent THC. This is the reason, the full-spectrum CBD (less than 0.3 percent THC) accounts for most of the revenue minted by this market.
Region Outlook
On the basis of the region, the continent of North America has been staying on the top spot in terms of revenue generation for the global CBD hemp oil market in the year 2021. Rising prevalence of cancer cases in the countries like the United States, and surging demand for newer type of effective medicines is helping the market grow in the region.
Competitive Landscape
The report provides both, qualitative and quantitative research of global CBD hemp oil market as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Some of the players operating in the global CBD hemp oil market are:
- 4 Corners Cannabis
- Absolute Nature Inc
- CBDistillery
- CHARLOTTE’S WEB
- CV Sciences, Inc
- Holmes Organics
- Cheef Botanicals
- Lazarus Naturals
- NuLeaf Naturals, LLC
- Premium Jane
- Social CBD
- Veritas Farms.
- ZATURAL
- Other Market Participants
Global CBD Hemp Oil Market:
By CBD Type
- Full-spectrum CBD (Less than 0.3 Percent THC)
- Broad-spectrum CBD (THC-free)
- CBD Isolate
By Product Type
- Tinctures
- Drops
- Sprays
- Others
By Type
- Flavored
- Unflavored/ Natural
By Strength
- Less than 350 mg
- 350 mg to 750 mg
- 750 mg to 1500 mg
- More than 1500 mg
By Medical Indication
- Anxiety & Depression
- Nausea
- Digestive Disorder
- Chronic Pain
- Infection Prevention
- Sleep Disorders
- Others
By Application
- Humans
- Animals/ Pets
By Distribution Channel
- Online
- Offline
- Retail Pharmacy
- Hospital Pharmacy
- Others
By Region
- North America (U.S., Canada, Mexico, Rest of North America)
- Europe (France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), Rest of Europe
- Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific
- Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa)
- Latin America (Brazil, Argentina, Rest of Latin America)
Table of Contents
1. Market Scope
1.1. Market
Segmentation
1.2. Years
Considered
1.2.1. Historic
Years: 2015 – 2021
1.2.2. Base
Year: 2022
1.2.3. Forecast
Years: 2023 - 2031
2. Key Target Audiences
3. Research Methodology
3.1. Primary
Research
3.1.1. Research
Questionnaire
3.1.2. Global
Percentage Breakdown
3.1.3. Primary
Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary
Research
3.2.1. Paid
Databases
3.2.2. Secondary
Sources
3.3. Market
Size Estimates
3.3.1. Top-Down
Approach
3.3.2. Bottom-Up
Approach
3.4. Data
Triangulation Methodology
3.5. Research
Assumptions
4. Recommendations and Insights from AMI’s Perspective**
5. Holistic Overview of CBD Hemp Oil Market
6. Market Synopsis: CBD
Hemp Oil Market
7. CBD Hemp Oil Market Analysis: Qualitative Perspective
7.1. Introduction
7.1.1. Product
Definition
7.1.2. Industry
Development
7.2. Market
Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.2.4. Challenges
7.3. Trends in
CBD Hemp Oil Market
7.4. Market
Determinants Radar Chart
7.5. Macro-Economic
and Micro-Economic Indicators: CBD Hemp Oil Market
7.6. Impact of
Covid-19 on CBD Hemp Oil Market
8. Global CBD Hemp Oil Market Analysis and Forecasts, 2023 -
2031
8.1. Overview
8.1.1. Global
CBD Hemp Oil Market Revenue (US$ Mn)
8.2. Global CBD
Hemp Oil Market Revenue (US$ Mn) and Forecasts, By CBD Type
8.2.1. Full-spectrum
CBD (Less than 0.3 Percent THC)
8.2.1.1. Definition
8.2.1.2. Market Estimation and Penetration, 2015 - 2022
8.2.1.3. Market Forecast, 2023 - 2031
8.2.1.4. Compound Annual Growth Rate (CAGR)
8.2.1.5. Regional Bifurcation
8.2.1.5.1. North America
8.2.1.5.1.1. Market
Estimation, 2015 - 2022
8.2.1.5.1.2. Market
Forecast, 2023 - 2031
8.2.1.5.2. Europe
8.2.1.5.2.1. Market
Estimation, 2015 - 2022
8.2.1.5.2.2. Market
Forecast, 2023 - 2031
8.2.1.5.3. Asia Pacific
8.2.1.5.3.1. Market
Estimation, 2015 - 2022
8.2.1.5.3.2. Market
Forecast, 2023 - 2031
8.2.1.5.4. Middle East and Africa
8.2.1.5.4.1. Market
Estimation, 2015 - 2022
8.2.1.5.4.2. Market
Forecast, 2023 - 2031
8.2.1.5.5. Latin America
8.2.1.5.5.1. Market
Estimation, 2015 - 2022
8.2.1.5.5.2. Market
Forecast, 2023 - 2031
8.2.2. Broad-spectrum
CBD (THC-free)
8.2.2.1. Definition
8.2.2.2. Market Estimation and Penetration, 2015 - 2022
8.2.2.3. Market Forecast, 2023 - 2031
8.2.2.4. Compound Annual Growth Rate (CAGR)
8.2.2.5. Regional Bifurcation
8.2.2.5.1. North America
8.2.2.5.1.1. Market
Estimation, 2015 - 2022
8.2.2.5.1.2. Market
Forecast, 2023 - 2031
8.2.2.5.2. Europe
8.2.2.5.2.1. Market
Estimation, 2015 - 2022
8.2.2.5.2.2. Market
Forecast, 2023 - 2031
8.2.2.5.3. Asia Pacific
8.2.2.5.3.1. Market
Estimation, 2015 - 2022
8.2.2.5.3.2. Market
Forecast, 2023 - 2031
8.2.2.5.4. Middle East and Africa
8.2.2.5.4.1. Market
Estimation, 2015 - 2022
8.2.2.5.4.2. Market
Forecast, 2023 - 2031
8.2.2.5.5. Latin America
8.2.2.5.5.1. Market
Estimation, 2015 - 2022
8.2.2.5.5.2. Market
Forecast, 2023 - 2031
8.2.3. CBD
Isolate
8.2.3.1. Definition
8.2.3.2. Market Estimation and Penetration, 2015 - 2022
8.2.3.3. Market Forecast, 2023 - 2031
8.2.3.4. Compound Annual Growth Rate (CAGR)
8.2.3.5. Regional Bifurcation
8.2.3.5.1. North America
8.2.3.5.1.1. Market
Estimation, 2015 - 2022
8.2.3.5.1.2. Market
Forecast, 2023 - 2031
8.2.3.5.2. Europe
8.2.3.5.2.1. Market
Estimation, 2015 - 2022
8.2.3.5.2.2. Market
Forecast, 2023 - 2031
8.2.3.5.3. Asia Pacific
8.2.3.5.3.1. Market
Estimation, 2015 - 2022
8.2.3.5.3.2. Market
Forecast, 2023 - 2031
8.2.3.5.4. Middle East and Africa
8.2.3.5.4.1. Market
Estimation, 2015 - 2022
8.2.3.5.4.2. Market
Forecast, 2023 - 2031
8.2.3.5.5. Latin America
8.2.3.5.5.1. Market
Estimation, 2015 - 2022
8.2.3.5.5.2. Market
Forecast, 2023 - 2031
8.3. Key
Segment for Channeling Investments
8.3.1. By CBD
Type
9. Global CBD Hemp Oil Market Analysis and Forecasts, 2023 -
2031
9.1. Overview
9.2. Global CBD
Hemp Oil Market Revenue (US$ Mn) and Forecasts, By Product Type
9.2.1. Tinctures
9.2.1.1. Definition
9.2.1.2. Market Estimation and Penetration, 2015 - 2022
9.2.1.3. Market Forecast, 2023 - 2031
9.2.1.4. Compound Annual Growth Rate (CAGR)
9.2.1.5. Regional Bifurcation
9.2.1.5.1. North America
9.2.1.5.1.1. Market
Estimation, 2015 - 2022
9.2.1.5.1.2. Market
Forecast, 2023 - 2031
9.2.1.5.2. Europe
9.2.1.5.2.1. Market
Estimation, 2015 - 2022
9.2.1.5.2.2. Market
Forecast, 2023 - 2031
9.2.1.5.3. Asia Pacific
9.2.1.5.3.1. Market
Estimation, 2015 - 2022
9.2.1.5.3.2. Market
Forecast, 2023 - 2031
9.2.1.5.4. Middle East and Africa
9.2.1.5.4.1. Market
Estimation, 2015 - 2022
9.2.1.5.4.2. Market
Forecast, 2023 - 2031
9.2.1.5.5. Latin America
9.2.1.5.5.1. Market
Estimation, 2015 - 2022
9.2.1.5.5.2. Market
Forecast, 2023 - 2031
9.2.2. Drops
9.2.2.1. Definition
9.2.2.2. Market Estimation and Penetration, 2015 - 2022
9.2.2.3. Market Forecast, 2023 - 2031
9.2.2.4. Compound Annual Growth Rate (CAGR)
9.2.2.5. Regional Bifurcation
9.2.2.5.1. North America
9.2.2.5.1.1. Market
Estimation, 2015 - 2022
9.2.2.5.1.2. Market
Forecast, 2023 - 2031
9.2.2.5.2. Europe
9.2.2.5.2.1. Market
Estimation, 2015 - 2022
9.2.2.5.2.2. Market
Forecast, 2023 - 2031
9.2.2.5.3. Asia Pacific
9.2.2.5.3.1. Market
Estimation, 2015 - 2022
9.2.2.5.3.2. Market
Forecast, 2023 - 2031
9.2.2.5.4. Middle East and Africa
9.2.2.5.4.1. Market
Estimation, 2015 - 2022
9.2.2.5.4.2. Market
Forecast, 2023 - 2031
9.2.2.5.5. Latin America
9.2.2.5.5.1. Market
Estimation, 2015 - 2022
9.2.2.5.5.2. Market
Forecast, 2023 - 2031
9.2.3. Sprays
9.2.3.1. Definition
9.2.3.2. Market Estimation and Penetration, 2015 - 2022
9.2.3.3. Market Forecast, 2023 - 2031
9.2.3.4. Compound Annual Growth Rate (CAGR)
9.2.3.5. Regional Bifurcation
9.2.3.5.1. North America
9.2.3.5.1.1. Market
Estimation, 2015 - 2022
9.2.3.5.1.2. Market
Forecast, 2023 - 2031
9.2.3.5.2. Europe
9.2.3.5.2.1. Market
Estimation, 2015 - 2022
9.2.3.5.2.2. Market
Forecast, 2023 - 2031
9.2.3.5.3. Asia Pacific
9.2.3.5.3.1. Market
Estimation, 2015 - 2022
9.2.3.5.3.2. Market
Forecast, 2023 - 2031
9.2.3.5.4. Middle East and Africa
9.2.3.5.4.1. Market
Estimation, 2015 - 2022
9.2.3.5.4.2. Market
Forecast, 2023 - 2031
9.2.3.5.5. Latin America
9.2.3.5.5.1. Market
Estimation, 2015 - 2022
9.2.3.5.5.2. Market
Forecast, 2023 - 2031
9.2.4. Others
9.2.4.1. Definition
9.2.4.2. Market Estimation and Penetration, 2015 - 2022
9.2.4.3. Market Forecast, 2023 - 2031
9.2.4.4. Compound Annual Growth Rate (CAGR)
9.2.4.5. Regional Bifurcation
9.2.4.5.1. North America
9.2.4.5.1.1. Market
Estimation, 2015 - 2022
9.2.4.5.1.2. Market
Forecast, 2023 - 2031
9.2.4.5.2. Europe
9.2.4.5.2.1. Market
Estimation, 2015 - 2022
9.2.4.5.2.2. Market
Forecast, 2023 - 2031
9.2.4.5.3. Asia Pacific
9.2.4.5.3.1. Market
Estimation, 2015 - 2022
9.2.4.5.3.2. Market
Forecast, 2023 - 2031
9.2.4.5.4. Middle East and Africa
9.2.4.5.4.1. Market
Estimation, 2015 - 2022
9.2.4.5.4.2. Market
Forecast, 2023 - 2031
9.2.4.5.5. Latin America
9.2.4.5.5.1. Market
Estimation, 2015 - 2022
9.2.4.5.5.2. Market
Forecast, 2023 - 2031
9.3. Key
Segment for Channeling Investments
9.3.1. By
Product Type
10. Global CBD Hemp Oil Market Analysis and Forecasts, 2023 -
2031
10.1. Overview
10.2. Global
CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By Type
10.2.1. Flavored
10.2.1.1. Definition
10.2.1.2. Market Estimation and Penetration, 2015 - 2022
10.2.1.3. Market Forecast, 2023 - 2031
10.2.1.4. Compound Annual Growth Rate (CAGR)
10.2.1.5. Regional Bifurcation
10.2.1.5.1. North America
10.2.1.5.1.1. Market
Estimation, 2015 - 2022
10.2.1.5.1.2. Market
Forecast, 2023 - 2031
10.2.1.5.2. Europe
10.2.1.5.2.1. Market
Estimation, 2015 - 2022
10.2.1.5.2.2. Market
Forecast, 2023 - 2031
10.2.1.5.3. Asia Pacific
10.2.1.5.3.1. Market
Estimation, 2015 - 2022
10.2.1.5.3.2. Market
Forecast, 2023 - 2031
10.2.1.5.4. Middle East and Africa
10.2.1.5.4.1. Market
Estimation, 2015 - 2022
10.2.1.5.4.2. Market
Forecast, 2023 - 2031
10.2.1.5.5. Latin America
10.2.1.5.5.1. Market
Estimation, 2015 - 2022
10.2.1.5.5.2. Market
Forecast, 2023 - 2031
10.2.2. Unflavored/
Natural
10.2.2.1. Definition
10.2.2.2. Market Estimation and Penetration, 2015 - 2022
10.2.2.3. Market Forecast, 2023 - 2031
10.2.2.4. Compound Annual Growth Rate (CAGR)
10.2.2.5. Regional Bifurcation
10.2.2.5.1. North America
10.2.2.5.1.1. Market
Estimation, 2015 - 2022
10.2.2.5.1.2. Market
Forecast, 2023 - 2031
10.2.2.5.2. Europe
10.2.2.5.2.1. Market
Estimation, 2015 - 2022
10.2.2.5.2.2. Market
Forecast, 2023 - 2031
10.2.2.5.3. Asia Pacific
10.2.2.5.3.1. Market
Estimation, 2015 - 2022
10.2.2.5.3.2. Market
Forecast, 2023 - 2031
10.2.2.5.4. Middle East and Africa
10.2.2.5.4.1. Market
Estimation, 2015 - 2022
10.2.2.5.4.2. Market
Forecast, 2023 - 2031
10.2.2.5.5. Latin America
10.2.2.5.5.1. Market
Estimation, 2015 - 2022
10.2.2.5.5.2. Market
Forecast, 2023 - 2031
10.3. Key
Segment for Channeling Investments
10.3.1. By Type
11. Global CBD Hemp Oil Market Analysis and Forecasts, 2023 -
2031
11.1. Overview
11.2. Global
CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By Strength
11.2.1. Less
than 350 mg
11.2.1.1. Definition
11.2.1.2. Market Estimation and Penetration, 2015 - 2022
11.2.1.3. Market Forecast, 2023 - 2031
11.2.1.4. Compound Annual Growth Rate (CAGR)
11.2.1.5. Regional Bifurcation
11.2.1.5.1. North America
11.2.1.5.1.1. Market
Estimation, 2015 - 2022
11.2.1.5.1.2. Market
Forecast, 2023 - 2031
11.2.1.5.2. Europe
11.2.1.5.2.1. Market
Estimation, 2015 - 2022
11.2.1.5.2.2. Market
Forecast, 2023 - 2031
11.2.1.5.3. Asia Pacific
11.2.1.5.3.1. Market
Estimation, 2015 - 2022
11.2.1.5.3.2. Market
Forecast, 2023 - 2031
11.2.1.5.4. Middle East and Africa
11.2.1.5.4.1. Market
Estimation, 2015 - 2022
11.2.1.5.4.2. Market
Forecast, 2023 - 2031
11.2.1.5.5. Latin America
11.2.1.5.5.1. Market
Estimation, 2015 - 2022
11.2.1.5.5.2. Market
Forecast, 2023 - 2031
11.2.2. 350 mg
to 750 mg
11.2.2.1. Definition
11.2.2.2. Market Estimation and Penetration, 2015 - 2022
11.2.2.3. Market Forecast, 2023 - 2031
11.2.2.4. Compound Annual Growth Rate (CAGR)
11.2.2.5. Regional Bifurcation
11.2.2.5.1. North America
11.2.2.5.1.1. Market
Estimation, 2015 - 2022
11.2.2.5.1.2. Market
Forecast, 2023 - 2031
11.2.2.5.2. Europe
11.2.2.5.2.1. Market
Estimation, 2015 - 2022
11.2.2.5.2.2. Market
Forecast, 2023 - 2031
11.2.2.5.3. Asia Pacific
11.2.2.5.3.1. Market
Estimation, 2015 - 2022
11.2.2.5.3.2. Market
Forecast, 2023 - 2031
11.2.2.5.4. Middle East and Africa
11.2.2.5.4.1. Market
Estimation, 2015 - 2022
11.2.2.5.4.2. Market
Forecast, 2023 - 2031
11.2.2.5.5. Latin America
11.2.2.5.5.1. Market
Estimation, 2015 - 2022
11.2.2.5.5.2. Market
Forecast, 2023 - 2031
11.2.3. 750 mg
to 1500 mg
11.2.3.1. Definition
11.2.3.2. Market Estimation and Penetration, 2015 - 2022
11.2.3.3. Market Forecast, 2023 - 2031
11.2.3.4. Compound Annual Growth Rate (CAGR)
11.2.3.5. Regional Bifurcation
11.2.3.5.1. North America
11.2.3.5.1.1. Market
Estimation, 2015 - 2022
11.2.3.5.1.2. Market
Forecast, 2023 - 2031
11.2.3.5.2. Europe
11.2.3.5.2.1. Market
Estimation, 2015 - 2022
11.2.3.5.2.2. Market
Forecast, 2023 - 2031
11.2.3.5.3. Asia Pacific
11.2.3.5.3.1. Market
Estimation, 2015 - 2022
11.2.3.5.3.2. Market
Forecast, 2023 - 2031
11.2.3.5.4. Middle East and Africa
11.2.3.5.4.1. Market
Estimation, 2015 - 2022
11.2.3.5.4.2. Market
Forecast, 2023 - 2031
11.2.3.5.5. Latin America
11.2.3.5.5.1. Market
Estimation, 2015 - 2022
11.2.3.5.5.2. Market
Forecast, 2023 - 2031
11.2.4. More
than 1500 mg
11.2.4.1. Definition
11.2.4.2. Market Estimation and Penetration, 2015 - 2022
11.2.4.3. Market Forecast, 2023 - 2031
11.2.4.4. Compound Annual Growth Rate (CAGR)
11.2.4.5. Regional Bifurcation
11.2.4.5.1. North America
11.2.4.5.1.1. Market
Estimation, 2015 - 2022
11.2.4.5.1.2. Market
Forecast, 2023 - 2031
11.2.4.5.2. Europe
11.2.4.5.2.1. Market
Estimation, 2015 - 2022
11.2.4.5.2.2. Market
Forecast, 2023 - 2031
11.2.4.5.3. Asia Pacific
11.2.4.5.3.1. Market
Estimation, 2015 - 2022
11.2.4.5.3.2. Market
Forecast, 2023 - 2031
11.2.4.5.4. Middle East and Africa
11.2.4.5.4.1. Market
Estimation, 2015 - 2022
11.2.4.5.4.2. Market
Forecast, 2023 - 2031
11.2.4.5.5. Latin America
11.2.4.5.5.1. Market
Estimation, 2015 - 2022
11.2.4.5.5.2. Market
Forecast, 2023 - 2031
11.3. Key
Segment for Channeling Investments
11.3.1. By
Strength
12. Global CBD Hemp Oil Market Analysis and Forecasts, 2023 -
2031
12.1. Overview
12.2. Global
CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By Medical Indication
12.2.1. Anxiety
and Depression
12.2.1.1. Definition
12.2.1.2. Market Estimation and Penetration, 2015 - 2022
12.2.1.3. Market Forecast, 2023 - 2031
12.2.1.4. Compound Annual Growth Rate (CAGR)
12.2.1.5. Regional Bifurcation
12.2.1.5.1. North America
12.2.1.5.1.1. Market
Estimation, 2015 - 2022
12.2.1.5.1.2. Market
Forecast, 2023 - 2031
12.2.1.5.2. Europe
12.2.1.5.2.1. Market
Estimation, 2015 - 2022
12.2.1.5.2.2. Market
Forecast, 2023 - 2031
12.2.1.5.3. Asia Pacific
12.2.1.5.3.1. Market
Estimation, 2015 - 2022
12.2.1.5.3.2. Market
Forecast, 2023 - 2031
12.2.1.5.4. Middle East and Africa
12.2.1.5.4.1. Market
Estimation, 2015 - 2022
12.2.1.5.4.2. Market
Forecast, 2023 - 2031
12.2.1.5.5. Latin America
12.2.1.5.5.1. Market
Estimation, 2015 - 2022
12.2.1.5.5.2. Market
Forecast, 2023 - 2031
12.2.2. Nausea
12.2.2.1. Definition
12.2.2.2. Market Estimation and Penetration, 2015 - 2022
12.2.2.3. Market Forecast, 2023 - 2031
12.2.2.4. Compound Annual Growth Rate (CAGR)
12.2.2.5. Regional Bifurcation
12.2.2.5.1. North America
12.2.2.5.1.1. Market
Estimation, 2015 - 2022
12.2.2.5.1.2. Market
Forecast, 2023 - 2031
12.2.2.5.2. Europe
12.2.2.5.2.1. Market
Estimation, 2015 - 2022
12.2.2.5.2.2. Market
Forecast, 2023 - 2031
12.2.2.5.3. Asia Pacific
12.2.2.5.3.1. Market
Estimation, 2015 - 2022
12.2.2.5.3.2. Market
Forecast, 2023 - 2031
12.2.2.5.4. Middle East and Africa
12.2.2.5.4.1. Market
Estimation, 2015 - 2022
12.2.2.5.4.2. Market
Forecast, 2023 - 2031
12.2.2.5.5. Latin America
12.2.2.5.5.1. Market
Estimation, 2015 - 2022
12.2.2.5.5.2. Market
Forecast, 2023 - 2031
12.2.3. Digestive
Disorder
12.2.3.1. Definition
12.2.3.2. Market Estimation and Penetration, 2015 - 2022
12.2.3.3. Market Forecast, 2023 - 2031
12.2.3.4. Compound Annual Growth Rate (CAGR)
12.2.3.5. Regional Bifurcation
12.2.3.5.1. North America
12.2.3.5.1.1. Market
Estimation, 2015 - 2022
12.2.3.5.1.2. Market
Forecast, 2023 - 2031
12.2.3.5.2. Europe
12.2.3.5.2.1. Market
Estimation, 2015 - 2022
12.2.3.5.2.2. Market
Forecast, 2023 - 2031
12.2.3.5.3. Asia Pacific
12.2.3.5.3.1. Market
Estimation, 2015 - 2022
12.2.3.5.3.2. Market
Forecast, 2023 - 2031
12.2.3.5.4. Middle East and Africa
12.2.3.5.4.1. Market
Estimation, 2015 - 2022
12.2.3.5.4.2. Market
Forecast, 2023 - 2031
12.2.3.5.5. Latin America
12.2.3.5.5.1. Market
Estimation, 2015 - 2022
12.2.3.5.5.2. Market
Forecast, 2023 - 2031
12.2.4. Chronic
Pain
12.2.4.1. Definition
12.2.4.2. Market Estimation and Penetration, 2015 - 2022
12.2.4.3. Market Forecast, 2023 - 2031
12.2.4.4. Compound Annual Growth Rate (CAGR)
12.2.4.5. Regional Bifurcation
12.2.4.5.1. North America
12.2.4.5.1.1. Market
Estimation, 2015 - 2022
12.2.4.5.1.2. Market
Forecast, 2023 - 2031
12.2.4.5.2. Europe
12.2.4.5.2.1. Market
Estimation, 2015 - 2022
12.2.4.5.2.2. Market
Forecast, 2023 - 2031
12.2.4.5.3. Asia Pacific
12.2.4.5.3.1. Market
Estimation, 2015 - 2022
12.2.4.5.3.2. Market
Forecast, 2023 - 2031
12.2.4.5.4. Middle East and Africa
12.2.4.5.4.1. Market
Estimation, 2015 - 2022
12.2.4.5.4.2. Market
Forecast, 2023 - 2031
12.2.4.5.5. Latin America
12.2.4.5.5.1. Market
Estimation, 2015 - 2022
12.2.4.5.5.2. Market
Forecast, 2023 - 2031
12.2.5. Infection
Prevention
12.2.5.1. Definition
12.2.5.2. Market Estimation and Penetration, 2015 - 2022
12.2.5.3. Market Forecast, 2023 - 2031
12.2.5.4. Compound Annual Growth Rate (CAGR)
12.2.5.5. Regional Bifurcation
12.2.5.5.1. North America
12.2.5.5.1.1. Market
Estimation, 2015 - 2022
12.2.5.5.1.2. Market
Forecast, 2023 - 2031
12.2.5.5.2. Europe
12.2.5.5.2.1. Market
Estimation, 2015 - 2022
12.2.5.5.2.2. Market
Forecast, 2023 - 2031
12.2.5.5.3. Asia Pacific
12.2.5.5.3.1. Market
Estimation, 2015 - 2022
12.2.5.5.3.2. Market
Forecast, 2023 - 2031
12.2.5.5.4. Middle East and Africa
12.2.5.5.4.1. Market
Estimation, 2015 - 2022
12.2.5.5.4.2. Market
Forecast, 2023 - 2031
12.2.5.5.5. Latin America
12.2.5.5.5.1. Market
Estimation, 2015 - 2022
12.2.5.5.5.2. Market
Forecast, 2023 - 2031
12.2.6. Sleep
Disorders
12.2.6.1. Definition
12.2.6.2. Market Estimation and Penetration, 2015 - 2022
12.2.6.3. Market Forecast, 2023 - 2031
12.2.6.4. Compound Annual Growth Rate (CAGR)
12.2.6.5. Regional Bifurcation
12.2.6.5.1. North America
12.2.6.5.1.1. Market
Estimation, 2015 - 2022
12.2.6.5.1.2. Market
Forecast, 2023 - 2031
12.2.6.5.2. Europe
12.2.6.5.2.1. Market
Estimation, 2015 - 2022
12.2.6.5.2.2. Market
Forecast, 2023 - 2031
12.2.6.5.3. Asia Pacific
12.2.6.5.3.1. Market
Estimation, 2015 - 2022
12.2.6.5.3.2. Market
Forecast, 2023 - 2031
12.2.6.5.4. Middle East and Africa
12.2.6.5.4.1. Market
Estimation, 2015 - 2022
12.2.6.5.4.2. Market
Forecast, 2023 - 2031
12.2.6.5.5. Latin America
12.2.6.5.5.1. Market
Estimation, 2015 - 2022
12.2.6.5.5.2. Market
Forecast, 2023 - 2031
12.2.7. Others
12.2.7.1. Definition
12.2.7.2. Market Estimation and Penetration, 2015 - 2022
12.2.7.3. Market Forecast, 2023 - 2031
12.2.7.4. Compound Annual Growth Rate (CAGR)
12.2.7.5. Regional Bifurcation
12.2.7.5.1. North America
12.2.7.5.1.1. Market
Estimation, 2015 - 2022
12.2.7.5.1.2. Market
Forecast, 2023 - 2031
12.2.7.5.2. Europe
12.2.7.5.2.1. Market
Estimation, 2015 - 2022
12.2.7.5.2.2. Market
Forecast, 2023 - 2031
12.2.7.5.3. Asia Pacific
12.2.7.5.3.1. Market
Estimation, 2015 - 2022
12.2.7.5.3.2. Market
Forecast, 2023 - 2031
12.2.7.5.4. Middle East and Africa
12.2.7.5.4.1. Market
Estimation, 2015 - 2022
12.2.7.5.4.2. Market
Forecast, 2023 - 2031
12.2.7.5.5. Latin America
12.2.7.5.5.1. Market
Estimation, 2015 - 2022
12.2.7.5.5.2. Market
Forecast, 2023 - 2031
12.3. Key
Segment for Channeling Investments
12.3.1. By
Medical Indication
13. Global CBD Hemp Oil Market Analysis and Forecasts, 2023 -
2031
13.1. Overview
13.2. Global
CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By Application
13.2.1. Humans
13.2.1.1. Definition
13.2.1.2. Market Estimation and Penetration, 2015 - 2022
13.2.1.3. Market Forecast, 2023 - 2031
13.2.1.4. Compound Annual Growth Rate (CAGR)
13.2.1.5. Regional Bifurcation
13.2.1.5.1. North America
13.2.1.5.1.1. Market
Estimation, 2015 - 2022
13.2.1.5.1.2. Market
Forecast, 2023 - 2031
13.2.1.5.2. Europe
13.2.1.5.2.1. Market
Estimation, 2015 - 2022
13.2.1.5.2.2. Market
Forecast, 2023 - 2031
13.2.1.5.3. Asia Pacific
13.2.1.5.3.1. Market
Estimation, 2015 - 2022
13.2.1.5.3.2. Market
Forecast, 2023 - 2031
13.2.1.5.4. Middle East and Africa
13.2.1.5.4.1. Market
Estimation, 2015 - 2022
13.2.1.5.4.2. Market
Forecast, 2023 - 2031
13.2.1.5.5. Latin America
13.2.1.5.5.1. Market
Estimation, 2015 - 2022
13.2.1.5.5.2. Market
Forecast, 2023 - 2031
13.2.2. Animals/
Pets
13.2.2.1. Definition
13.2.2.2. Market Estimation and Penetration, 2015 - 2022
13.2.2.3. Market Forecast, 2023 - 2031
13.2.2.4. Compound Annual Growth Rate (CAGR)
13.2.2.5. Regional Bifurcation
13.2.2.5.1. North America
13.2.2.5.1.1. Market
Estimation, 2015 - 2022
13.2.2.5.1.2. Market
Forecast, 2023 - 2031
13.2.2.5.2. Europe
13.2.2.5.2.1. Market
Estimation, 2015 - 2022
13.2.2.5.2.2. Market
Forecast, 2023 - 2031
13.2.2.5.3. Asia Pacific
13.2.2.5.3.1. Market
Estimation, 2015 - 2022
13.2.2.5.3.2. Market
Forecast, 2023 - 2031
13.2.2.5.4. Middle East and Africa
13.2.2.5.4.1. Market
Estimation, 2015 - 2022
13.2.2.5.4.2. Market
Forecast, 2023 - 2031
13.2.2.5.5. Latin America
13.2.2.5.5.1. Market
Estimation, 2015 - 2022
13.2.2.5.5.2. Market
Forecast, 2023 - 2031
13.3. Key
Segment for Channeling Investments
13.3.1. By
Application
14. Global CBD Hemp Oil Market Analysis and Forecasts, 2023 -
2031
14.1. Overview
14.2. Global
CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
14.2.1. Online
14.2.1.1. Definition
14.2.1.2. Market Estimation and Penetration, 2015 - 2022
14.2.1.3. Market Forecast, 2023 - 2031
14.2.1.4. Compound Annual Growth Rate (CAGR)
14.2.1.5. Regional Bifurcation
14.2.1.5.1. North America
14.2.1.5.1.1. Market
Estimation, 2015 - 2022
14.2.1.5.1.2. Market
Forecast, 2023 - 2031
14.2.1.5.2. Europe
14.2.1.5.2.1. Market
Estimation, 2015 - 2022
14.2.1.5.2.2. Market
Forecast, 2023 - 2031
14.2.1.5.3. Asia Pacific
14.2.1.5.3.1. Market
Estimation, 2015 - 2022
14.2.1.5.3.2. Market
Forecast, 2023 - 2031
14.2.1.5.4. Middle East and Africa
14.2.1.5.4.1. Market
Estimation, 2015 - 2022
14.2.1.5.4.2. Market
Forecast, 2023 - 2031
14.2.1.5.5. Latin America
14.2.1.5.5.1. Market
Estimation, 2015 - 2022
14.2.1.5.5.2. Market
Forecast, 2023 - 2031
14.2.2. Offline
(Definition, Market Estimation and Penetration, 2015 - 2022, Market Estimation
(2015 - 2022), Market Forecast (2023 - 2031), Compound Annual Growth Rate
(CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East
and Africa, Latin America) and Information on Retail Pharmacy, Hospital
Pharmacy, Others)
14.2.2.1. Retail Pharmacy
14.2.2.2. Hospital Pharmacy
14.2.2.3. Others
14.3. Key
Segment for Channeling Investments
14.3.1. By
Distribution Channel
15. North America CBD Hemp Oil Market Analysis and Forecasts, 2023
- 2031
15.1. Overview
15.1.1. North
America CBD Hemp Oil Market Revenue (US$ Mn)
15.2. North
America CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By CBD Type
15.2.1. Full-spectrum
CBD (Less than 0.3 Percent THC)
15.2.2. Broad-spectrum
CBD (THC-free)
15.2.3. CBD
Isolate
15.3. North
America CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By Product Type
15.3.1. Tinctures
15.3.2. Drops
15.3.3. Sprays
15.3.4. Others
15.4. North
America CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By Type
15.4.1. Flavored
15.4.2. Unflavored/
Natural
15.5. North
America CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By Strength
15.5.1. Less
than 350 mg
15.5.2. 350 mg
to 750 mg
15.5.3. 750 mg
to 1500 mg
15.5.4. More
than 1500 mg
15.6. North
America CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By Medical
Indication
15.6.1. Anxiety
and Depression
15.6.2. Nausea
15.6.3. Digestive
Disorder
15.6.4. Chronic
Pain
15.6.5. Infection
Prevention
15.6.6. Sleep
Disorders
15.6.7. Others
15.7. North
America CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By Application
15.7.1. Humans
15.7.2. Animals/
Pets
15.8. North
America CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
15.8.1. Online
15.8.2. Offline
15.8.2.1. Retail Pharmacy
15.8.2.2. Hospital Pharmacy
15.8.2.3. Others
15.9. North
America CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By Country
15.9.1. U.S
15.9.1.1. U.S CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By CBD
Type
15.9.1.1.1. Full-spectrum CBD (Less than 0.3 Percent THC)
15.9.1.1.2. Broad-spectrum CBD (THC-free)
15.9.1.1.3. CBD Isolate
15.9.1.2. U.S CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Product Type
15.9.1.2.1. Tinctures
15.9.1.2.2. Drops
15.9.1.2.3. Sprays
15.9.1.2.4. Others
15.9.1.3. U.S CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Type
15.9.1.3.1. Flavored
15.9.1.3.2. Unflavored/ Natural
15.9.1.4. U.S CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Strength
15.9.1.4.1. Less than 350 mg
15.9.1.4.2. 350 mg to 750 mg
15.9.1.4.3. 750 mg to 1500 mg
15.9.1.4.4. More than 1500 mg
15.9.1.5. U.S CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Medical Indication
15.9.1.5.1. Anxiety and Depression
15.9.1.5.2. Nausea
15.9.1.5.3. Digestive Disorder
15.9.1.5.4. Chronic Pain
15.9.1.5.5. Infection Prevention
15.9.1.5.6. Sleep Disorders
15.9.1.5.7. Others
15.9.1.6. U.S CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Application
15.9.1.6.1. Humans
15.9.1.6.2. Animals/ Pets
15.9.1.7. U.S CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
15.9.1.7.1. Online
15.9.1.7.2. Offline
15.9.1.7.2.1. Retail
Pharmacy
15.9.1.7.2.2. Hospital
Pharmacy
15.9.1.7.2.3. Others
15.9.2. Canada
15.9.2.1. Canada CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
CBD Type
15.9.2.1.1. Full-spectrum CBD (Less than 0.3 Percent THC)
15.9.2.1.2. Broad-spectrum CBD (THC-free)
15.9.2.1.3. CBD Isolate
15.9.2.2. Canada CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Product Type
15.9.2.2.1. Tinctures
15.9.2.2.2. Drops
15.9.2.2.3. Sprays
15.9.2.2.4. Others
15.9.2.3. Canada CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Type
15.9.2.3.1. Flavored
15.9.2.3.2. Unflavored/ Natural
15.9.2.4. Canada CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Strength
15.9.2.4.1. Less than 350 mg
15.9.2.4.2. 350 mg to 750 mg
15.9.2.4.3. 750 mg to 1500 mg
15.9.2.4.4. More than 1500 mg
15.9.2.5. Canada CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Medical Indication
15.9.2.5.1. Anxiety and Depression
15.9.2.5.2. Nausea
15.9.2.5.3. Digestive Disorder
15.9.2.5.4. Chronic Pain
15.9.2.5.5. Infection Prevention
15.9.2.5.6. Sleep Disorders
15.9.2.5.7. Others
15.9.2.6. Canada CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Application
15.9.2.6.1. Humans
15.9.2.6.2. Animals/ Pets
15.9.2.7. Canada CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
15.9.2.7.1. Online
15.9.2.7.2. Offline
15.9.2.7.2.1. Retail
Pharmacy
15.9.2.7.2.2. Hospital
Pharmacy
15.9.2.7.2.3. Others
15.9.3. Mexico
15.9.3.1. Mexico CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
CBD Type
15.9.3.1.1. Full-spectrum CBD (Less than 0.3 Percent THC)
15.9.3.1.2. Broad-spectrum CBD (THC-free)
15.9.3.1.3. CBD Isolate
15.9.3.2. Mexico CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Product Type
15.9.3.2.1. Tinctures
15.9.3.2.2. Drops
15.9.3.2.3. Sprays
15.9.3.2.4. Others
15.9.3.3. Mexico CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Type
15.9.3.3.1. Flavored
15.9.3.3.2. Unflavored/ Natural
15.9.3.4. Mexico CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Strength
15.9.3.4.1. Less than 350 mg
15.9.3.4.2. 350 mg to 750 mg
15.9.3.4.3. 750 mg to 1500 mg
15.9.3.4.4. More than 1500 mg
15.9.3.5. Mexico CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Medical Indication
15.9.3.5.1. Anxiety and Depression
15.9.3.5.2. Nausea
15.9.3.5.3. Digestive Disorder
15.9.3.5.4. Chronic Pain
15.9.3.5.5. Infection Prevention
15.9.3.5.6. Sleep Disorders
15.9.3.5.7. Others
15.9.3.6. Mexico CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Application
15.9.3.6.1. Humans
15.9.3.6.2. Animals/ Pets
15.9.3.7. Mexico CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
15.9.3.7.1. Online
15.9.3.7.2. Offline
15.9.3.7.2.1. Retail
Pharmacy
15.9.3.7.2.2. Hospital
Pharmacy
15.9.3.7.2.3. Others
15.9.4. Rest of
North America
15.9.4.1. Rest of North America CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By CBD Type
15.9.4.1.1. Full-spectrum CBD (Less than 0.3 Percent THC)
15.9.4.1.2. Broad-spectrum CBD (THC-free)
15.9.4.1.3. CBD Isolate
15.9.4.2. Rest of North America CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By Product Type
15.9.4.2.1. Tinctures
15.9.4.2.2. Drops
15.9.4.2.3. Sprays
15.9.4.2.4. Others
15.9.4.3. Rest of North America CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By Type
15.9.4.3.1. Flavored
15.9.4.3.2. Unflavored/ Natural
15.9.4.4. Rest of North America CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By Strength
15.9.4.4.1. Less than 350 mg
15.9.4.4.2. 350 mg to 750 mg
15.9.4.4.3. 750 mg to 1500 mg
15.9.4.4.4. More than 1500 mg
15.9.4.5. Rest of North America CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By Medical Indication
15.9.4.5.1. Anxiety and Depression
15.9.4.5.2. Nausea
15.9.4.5.3. Digestive Disorder
15.9.4.5.4. Chronic Pain
15.9.4.5.5. Infection Prevention
15.9.4.5.6. Sleep Disorders
15.9.4.5.7. Others
15.9.4.6. Rest of North America CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By Application
15.9.4.6.1. Humans
15.9.4.6.2. Animals/ Pets
15.9.4.7. Rest of North America CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
15.9.4.7.1. Online
15.9.4.7.2. Offline
15.9.4.7.2.1. Retail
Pharmacy
15.9.4.7.2.2. Hospital
Pharmacy
15.9.4.7.2.3. Others
15.10. Key
Segment for Channeling Investments
15.10.1. By
Country
15.10.2. By CBD
Type
15.10.3. By
Product Type
15.10.4. By
Type
15.10.5. By Strength
15.10.6. By
Medical Indication
15.10.7. By
Application
15.10.8. By
Distribution Channel
16. Europe CBD Hemp Oil Market Analysis and Forecasts, 2023 -
2031
16.1. Overview
16.1.1. Europe
CBD Hemp Oil Market Revenue (US$ Mn)
16.2. Europe
CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By CBD Type
16.2.1. Full-spectrum
CBD (Less than 0.3 Percent THC)
16.2.2. Broad-spectrum
CBD (THC-free)
16.2.3. CBD
Isolate
16.3. Europe
CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By Product Type
16.3.1. Tinctures
16.3.2. Drops
16.3.3. Sprays
16.3.4. Others
16.4. Europe
CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By Type
16.4.1. Flavored
16.4.2. Unflavored/
Natural
16.5. Europe
CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By Strength
16.5.1. Less
than 350 mg
16.5.2. 350 mg
to 750 mg
16.5.3. 750 mg
to 1500 mg
16.5.4. More
than 1500 mg
16.6. Europe
CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By Medical Indication
16.6.1. Anxiety
and Depression
16.6.2. Nausea
16.6.3. Digestive
Disorder
16.6.4. Chronic
Pain
16.6.5. Infection
Prevention
16.6.6. Sleep
Disorders
16.6.7. Others
16.7. Europe
CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By Application
16.7.1. Humans
16.7.2. Animals/
Pets
16.8. Europe
CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
16.8.1. Online
16.8.2. Offline
16.8.2.1. Retail Pharmacy
16.8.2.2. Hospital Pharmacy
16.8.2.3. Others
16.9. Europe
CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By Country
16.9.1. France
16.9.1.1. France CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By CBD
Type
16.9.1.1.1. Full-spectrum CBD (Less than 0.3 Percent THC)
16.9.1.1.2. Broad-spectrum CBD (THC-free)
16.9.1.1.3. CBD Isolate
16.9.1.2. France CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Product Type
16.9.1.2.1. Tinctures
16.9.1.2.2. Drops
16.9.1.2.3. Sprays
16.9.1.2.4. Others
16.9.1.3. France CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Type
16.9.1.3.1. Flavored
16.9.1.3.2. Unflavored/ Natural
16.9.1.4. France CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Strength
16.9.1.4.1. Less than 350 mg
16.9.1.4.2. 350 mg to 750 mg
16.9.1.4.3. 750 mg to 1500 mg
16.9.1.4.4. More than 1500 mg
16.9.1.5. France CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Medical Indication
16.9.1.5.1. Anxiety and Depression
16.9.1.5.2. Nausea
16.9.1.5.3. Digestive Disorder
16.9.1.5.4. Chronic Pain
16.9.1.5.5. Infection Prevention
16.9.1.5.6. Sleep Disorders
16.9.1.5.7. Others
16.9.1.6. France CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Application
16.9.1.6.1. Humans
16.9.1.6.2. Animals/ Pets
16.9.1.7. France CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
16.9.1.7.1. Online
16.9.1.7.2. Offline
16.9.1.7.2.1. Retail
Pharmacy
16.9.1.7.2.2. Hospital
Pharmacy
16.9.1.7.2.3. Others
16.9.2. The UK
16.9.2.1. The UK CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
CBD Type
16.9.2.1.1. Full-spectrum CBD (Less than 0.3 Percent THC)
16.9.2.1.2. Broad-spectrum CBD (THC-free)
16.9.2.1.3. CBD Isolate
16.9.2.2. The UK CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Product Type
16.9.2.2.1. Tinctures
16.9.2.2.2. Drops
16.9.2.2.3. Sprays
16.9.2.2.4. Others
16.9.2.3. The UK CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Type
16.9.2.3.1. Flavored
16.9.2.3.2. Unflavored/ Natural
16.9.2.4. The UK CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Strength
16.9.2.4.1. Less than 350 mg
16.9.2.4.2. 350 mg to 750 mg
16.9.2.4.3. 750 mg to 1500 mg
16.9.2.4.4. More than 1500 mg
16.9.2.5. The UK CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Medical Indication
16.9.2.5.1. Anxiety and Depression
16.9.2.5.2. Nausea
16.9.2.5.3. Digestive Disorder
16.9.2.5.4. Chronic Pain
16.9.2.5.5. Infection Prevention
16.9.2.5.6. Sleep Disorders
16.9.2.5.7. Others
16.9.2.6. The UK CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Application
16.9.2.6.1. Humans
16.9.2.6.2. Animals/ Pets
16.9.2.7. The UK CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
16.9.2.7.1. Online
16.9.2.7.2. Offline
16.9.2.7.2.1. Retail
Pharmacy
16.9.2.7.2.2. Hospital
Pharmacy
16.9.2.7.2.3. Others
16.9.3. Spain
16.9.3.1. Spain CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
CBD Type
16.9.3.1.1. Full-spectrum CBD (Less than 0.3 Percent THC)
16.9.3.1.2. Broad-spectrum CBD (THC-free)
16.9.3.1.3. CBD Isolate
16.9.3.2. Spain CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Product Type
16.9.3.2.1. Tinctures
16.9.3.2.2. Drops
16.9.3.2.3. Sprays
16.9.3.2.4. Others
16.9.3.3. Spain CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Type
16.9.3.3.1. Flavored
16.9.3.3.2. Unflavored/ Natural
16.9.3.4. Spain CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Strength
16.9.3.4.1. Less than 350 mg
16.9.3.4.2. 350 mg to 750 mg
16.9.3.4.3. 750 mg to 1500 mg
16.9.3.4.4. More than 1500 mg
16.9.3.5. Spain CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Medical Indication
16.9.3.5.1. Anxiety and Depression
16.9.3.5.2. Nausea
16.9.3.5.3. Digestive Disorder
16.9.3.5.4. Chronic Pain
16.9.3.5.5. Infection Prevention
16.9.3.5.6. Sleep Disorders
16.9.3.5.7. Others
16.9.3.6. Spain CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Application
16.9.3.6.1. Humans
16.9.3.6.2. Animals/ Pets
16.9.3.7. Spain CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
16.9.3.7.1. Online
16.9.3.7.2. Offline
16.9.3.7.2.1. Retail
Pharmacy
16.9.3.7.2.2. Hospital
Pharmacy
16.9.3.7.2.3. Others
16.9.4. Germany
16.9.4.1. Germany CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
CBD Type
16.9.4.1.1. Full-spectrum CBD (Less than 0.3 Percent THC)
16.9.4.1.2. Broad-spectrum CBD (THC-free)
16.9.4.1.3. CBD Isolate
16.9.4.2. Germany CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Product Type
16.9.4.2.1. Tinctures
16.9.4.2.2. Drops
16.9.4.2.3. Sprays
16.9.4.2.4. Others
16.9.4.3. Germany CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Type
16.9.4.3.1. Flavored
16.9.4.3.2. Unflavored/ Natural
16.9.4.4. Germany CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Strength
16.9.4.4.1. Less than 350 mg
16.9.4.4.2. 350 mg to 750 mg
16.9.4.4.3. 750 mg to 1500 mg
16.9.4.4.4. More than 1500 mg
16.9.4.5. Germany CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Medical Indication
16.9.4.5.1. Anxiety and Depression
16.9.4.5.2. Nausea
16.9.4.5.3. Digestive Disorder
16.9.4.5.4. Chronic Pain
16.9.4.5.5. Infection Prevention
16.9.4.5.6. Sleep Disorders
16.9.4.5.7. Others
16.9.4.6. Germany CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Application
16.9.4.6.1. Humans
16.9.4.6.2. Animals/ Pets
16.9.4.7. Germany CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
16.9.4.7.1. Online
16.9.4.7.2. Offline
16.9.4.7.2.1. Retail
Pharmacy
16.9.4.7.2.2. Hospital
Pharmacy
16.9.4.7.2.3. Others
16.9.5. Italy
16.9.5.1. Italy CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
CBD Type
16.9.5.1.1. Full-spectrum CBD (Less than 0.3 Percent THC)
16.9.5.1.2. Broad-spectrum CBD (THC-free)
16.9.5.1.3. CBD Isolate
16.9.5.2. Italy CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Product Type
16.9.5.2.1. Tinctures
16.9.5.2.2. Drops
16.9.5.2.3. Sprays
16.9.5.2.4. Others
16.9.5.3. Italy CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Type
16.9.5.3.1. Flavored
16.9.5.3.2. Unflavored/ Natural
16.9.5.4. Italy CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Strength
16.9.5.4.1. Less than 350 mg
16.9.5.4.2. 350 mg to 750 mg
16.9.5.4.3. 750 mg to 1500 mg
16.9.5.4.4. More than 1500 mg
16.9.5.5. Italy CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Medical Indication
16.9.5.5.1. Anxiety and Depression
16.9.5.5.2. Nausea
16.9.5.5.3. Digestive Disorder
16.9.5.5.4. Chronic Pain
16.9.5.5.5. Infection Prevention
16.9.5.5.6. Sleep Disorders
16.9.5.5.7. Others
16.9.5.6. Italy CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Application
16.9.5.6.1. Humans
16.9.5.6.2. Animals/ Pets
16.9.5.7. Italy CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
16.9.5.7.1. Online
16.9.5.7.2. Offline
16.9.5.7.2.1. Retail
Pharmacy
16.9.5.7.2.2. Hospital
Pharmacy
16.9.5.7.2.3. Others
16.9.6. Nordic
Countries
16.9.6.1. Nordic Countries CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By CBD Type
16.9.6.1.1. Full-spectrum CBD (Less than 0.3 Percent THC)
16.9.6.1.2. Broad-spectrum CBD (THC-free)
16.9.6.1.3. CBD Isolate
16.9.6.2. Nordic Countries CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By Product Type
16.9.6.2.1. Tinctures
16.9.6.2.2. Drops
16.9.6.2.3. Sprays
16.9.6.2.4. Others
16.9.6.3. Nordic Countries CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By Type
16.9.6.3.1. Flavored
16.9.6.3.2. Unflavored/ Natural
16.9.6.4. Nordic Countries CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By Strength
16.9.6.4.1. Less than 350 mg
16.9.6.4.2. 350 mg to 750 mg
16.9.6.4.3. 750 mg to 1500 mg
16.9.6.4.4. More than 1500 mg
16.9.6.5. Nordic Countries CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By Medical Indication
16.9.6.5.1. Anxiety and Depression
16.9.6.5.2. Nausea
16.9.6.5.3. Digestive Disorder
16.9.6.5.4. Chronic Pain
16.9.6.5.5. Infection Prevention
16.9.6.5.6. Sleep Disorders
16.9.6.5.7. Others
16.9.6.6. Nordic Countries CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By Application
16.9.6.6.1. Humans
16.9.6.6.2. Animals/ Pets
16.9.6.7. Nordic Countries CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
16.9.6.7.1. Online
16.9.6.7.2. Offline
16.9.6.7.2.1. Retail
Pharmacy
16.9.6.7.2.2. Hospital
Pharmacy
16.9.6.7.2.3. Others
16.9.6.8. Nordic Countries CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By Country
16.9.6.8.1. Denmark
16.9.6.8.2. Finland
16.9.6.8.3. Iceland
16.9.6.8.4. Sweden
16.9.6.8.5. Norway
16.9.7. Benelux
Union
16.9.7.1. Benelux Union CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts,
By CBD Type
16.9.7.1.1. Full-spectrum CBD (Less than 0.3 Percent THC)
16.9.7.1.2. Broad-spectrum CBD (THC-free)
16.9.7.1.3. CBD Isolate
16.9.7.2. Benelux Union CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By Product Type
16.9.7.2.1. Tinctures
16.9.7.2.2. Drops
16.9.7.2.3. Sprays
16.9.7.2.4. Others
16.9.7.3. Benelux Union CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By Type
16.9.7.3.1. Flavored
16.9.7.3.2. Unflavored/ Natural
16.9.7.4. Benelux Union CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By Strength
16.9.7.4.1. Less than 350 mg
16.9.7.4.2. 350 mg to 750 mg
16.9.7.4.3. 750 mg to 1500 mg
16.9.7.4.4. More than 1500 mg
16.9.7.5. Benelux Union CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By Medical Indication
16.9.7.5.1. Anxiety and Depression
16.9.7.5.2. Nausea
16.9.7.5.3. Digestive Disorder
16.9.7.5.4. Chronic Pain
16.9.7.5.5. Infection Prevention
16.9.7.5.6. Sleep Disorders
16.9.7.5.7. Others
16.9.7.6. Benelux Union CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By Application
16.9.7.6.1. Humans
16.9.7.6.2. Animals/ Pets
16.9.7.7. Benelux Union CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
16.9.7.7.1. Online
16.9.7.7.2. Offline
16.9.7.7.2.1. Retail
Pharmacy
16.9.7.7.2.2. Hospital
Pharmacy
16.9.7.7.2.3. Others
16.9.7.8. Benelux Union CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By Country
16.9.7.8.1. Belgium
16.9.7.8.2. The Netherlands
16.9.7.8.3. Luxembourg
16.9.8. Rest of
Europe
16.9.8.1. Rest of Europe CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By CBD Type
16.9.8.1.1. Full-spectrum CBD (Less than 0.3 Percent THC)
16.9.8.1.2. Broad-spectrum CBD (THC-free)
16.9.8.1.3. CBD Isolate
16.9.8.2. Rest of Europe CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts,
By Product Type
16.9.8.2.1. Tinctures
16.9.8.2.2. Drops
16.9.8.2.3. Sprays
16.9.8.2.4. Others
16.9.8.3. Rest of Europe CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By Type
16.9.8.3.1. Flavored
16.9.8.3.2. Unflavored/ Natural
16.9.8.4. Rest of Europe CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By Strength
16.9.8.4.1. Less than 350 mg
16.9.8.4.2. 350 mg to 750 mg
16.9.8.4.3. 750 mg to 1500 mg
16.9.8.4.4. More than 1500 mg
16.9.8.5. Rest of Europe CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By Medical Indication
16.9.8.5.1. Anxiety and Depression
16.9.8.5.2. Nausea
16.9.8.5.3. Digestive Disorder
16.9.8.5.4. Chronic Pain
16.9.8.5.5. Infection Prevention
16.9.8.5.6. Sleep Disorders
16.9.8.5.7. Others
16.9.8.6. Rest of Europe CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By Application
16.9.8.6.1. Humans
16.9.8.6.2. Animals/ Pets
16.9.8.7. Rest of Europe CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
16.9.8.7.1. Online
16.9.8.7.2. Offline
16.9.8.7.2.1. Retail
Pharmacy
16.9.8.7.2.2. Hospital
Pharmacy
16.9.8.7.2.3. Others
16.10. Key Segment
for Channeling Investments
16.10.1. By
Country
16.10.2. By CBD
Type
16.10.3. By
Product Type
16.10.4. By
Type
16.10.5. By
Strength
16.10.6. By
Medical Indication
16.10.7. By
Application
16.10.8. By
Distribution Channel
17. Asia Pacific CBD Hemp Oil Market Analysis and Forecasts, 2023
- 2031
17.1. Overview
17.1.1. Asia
Pacific CBD Hemp Oil Market Revenue (US$ Mn)
17.2. Asia
Pacific CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By CBD Type
17.2.1. Full-spectrum
CBD (Less than 0.3 Percent THC)
17.2.2. Broad-spectrum
CBD (THC-free)
17.2.3. CBD
Isolate
17.3. Asia
Pacific CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By Product Type
17.3.1. Tinctures
17.3.2. Drops
17.3.3. Sprays
17.3.4. Others
17.4. Asia
Pacific CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By Type
17.4.1. Flavored
17.4.2. Unflavored/
Natural
17.5. Asia
Pacific CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By Strength
17.5.1. Less
than 350 mg
17.5.2. 350 mg
to 750 mg
17.5.3. 750 mg
to 1500 mg
17.5.4. More
than 1500 mg
17.6. Asia
Pacific CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By Medical
Indication
17.6.1. Anxiety
and Depression
17.6.2. Nausea
17.6.3. Digestive
Disorder
17.6.4. Chronic
Pain
17.6.5. Infection
Prevention
17.6.6. Sleep
Disorders
17.6.7. Others
17.7. Asia
Pacific CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By Application
17.7.1. Humans
17.7.2. Animals/
Pets
17.8. Asia
Pacific CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
17.8.1. Online
17.8.2. Offline
17.8.2.1. Retail Pharmacy
17.8.2.2. Hospital Pharmacy
17.8.2.3. Others
17.9. Asia
Pacific CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By Country
17.9.1. China
17.9.1.1. China CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
CBD Type
17.9.1.1.1. Full-spectrum CBD (Less than 0.3 Percent THC)
17.9.1.1.2. Broad-spectrum CBD (THC-free)
17.9.1.1.3. CBD Isolate
17.9.1.2. China CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Product Type
17.9.1.2.1. Tinctures
17.9.1.2.2. Drops
17.9.1.2.3. Sprays
17.9.1.2.4. Others
17.9.1.3. China CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Type
17.9.1.3.1. Flavored
17.9.1.3.2. Unflavored/ Natural
17.9.1.4. China CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Strength
17.9.1.4.1. Less than 350 mg
17.9.1.4.2. 350 mg to 750 mg
17.9.1.4.3. 750 mg to 1500 mg
17.9.1.4.4. More than 1500 mg
17.9.1.5. China CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Medical Indication
17.9.1.5.1. Anxiety and Depression
17.9.1.5.2. Nausea
17.9.1.5.3. Digestive Disorder
17.9.1.5.4. Chronic Pain
17.9.1.5.5. Infection Prevention
17.9.1.5.6. Sleep Disorders
17.9.1.5.7. Others
17.9.1.6. China CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Application
17.9.1.6.1. Humans
17.9.1.6.2. Animals/ Pets
17.9.1.7. China CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
17.9.1.7.1. Online
17.9.1.7.2. Offline
17.9.1.7.2.1. Retail
Pharmacy
17.9.1.7.2.2. Hospital
Pharmacy
17.9.1.7.2.3. Others
17.9.2. Japan
17.9.2.1. Japan CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
CBD Type
17.9.2.1.1. Full-spectrum CBD (Less than 0.3 Percent THC)
17.9.2.1.2. Broad-spectrum CBD (THC-free)
17.9.2.1.3. CBD Isolate
17.9.2.2. Japan CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Product Type
17.9.2.2.1. Tinctures
17.9.2.2.2. Drops
17.9.2.2.3. Sprays
17.9.2.2.4. Others
17.9.2.3. Japan CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Type
17.9.2.3.1. Flavored
17.9.2.3.2. Unflavored/ Natural
17.9.2.4. Japan CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Strength
17.9.2.4.1. Less than 350 mg
17.9.2.4.2. 350 mg to 750 mg
17.9.2.4.3. 750 mg to 1500 mg
17.9.2.4.4. More than 1500 mg
17.9.2.5. Japan CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Medical Indication
17.9.2.5.1. Anxiety and Depression
17.9.2.5.2. Nausea
17.9.2.5.3. Digestive Disorder
17.9.2.5.4. Chronic Pain
17.9.2.5.5. Infection Prevention
17.9.2.5.6. Sleep Disorders
17.9.2.5.7. Others
17.9.2.6. Japan CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Application
17.9.2.6.1. Humans
17.9.2.6.2. Animals/ Pets
17.9.2.7. Japan CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
17.9.2.7.1. Online
17.9.2.7.2. Offline
17.9.2.7.2.1. Retail
Pharmacy
17.9.2.7.2.2. Hospital
Pharmacy
17.9.2.7.2.3. Others
17.9.3. India
17.9.3.1. India CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
CBD Type
17.9.3.1.1. Full-spectrum CBD (Less than 0.3 Percent THC)
17.9.3.1.2. Broad-spectrum CBD (THC-free)
17.9.3.1.3. CBD Isolate
17.9.3.2. India CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Product Type
17.9.3.2.1. Tinctures
17.9.3.2.2. Drops
17.9.3.2.3. Sprays
17.9.3.2.4. Others
17.9.3.3. India CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Type
17.9.3.3.1. Flavored
17.9.3.3.2. Unflavored/ Natural
17.9.3.4. India CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Strength
17.9.3.4.1. Less than 350 mg
17.9.3.4.2. 350 mg to 750 mg
17.9.3.4.3. 750 mg to 1500 mg
17.9.3.4.4. More than 1500 mg
17.9.3.5. India CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Medical Indication
17.9.3.5.1. Anxiety and Depression
17.9.3.5.2. Nausea
17.9.3.5.3. Digestive Disorder
17.9.3.5.4. Chronic Pain
17.9.3.5.5. Infection Prevention
17.9.3.5.6. Sleep Disorders
17.9.3.5.7. Others
17.9.3.6. India CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Application
17.9.3.6.1. Humans
17.9.3.6.2. Animals/ Pets
17.9.3.7. India CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
17.9.3.7.1. Online
17.9.3.7.2. Offline
17.9.3.7.2.1. Retail
Pharmacy
17.9.3.7.2.2. Hospital
Pharmacy
17.9.3.7.2.3. Others
17.9.4. New
Zealand
17.9.4.1. New Zealand CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By CBD Type
17.9.4.1.1. Full-spectrum CBD (Less than 0.3 Percent THC)
17.9.4.1.2. Broad-spectrum CBD (THC-free)
17.9.4.1.3. CBD Isolate
17.9.4.2. New Zealand CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By Product Type
17.9.4.2.1. Tinctures
17.9.4.2.2. Drops
17.9.4.2.3. Sprays
17.9.4.2.4. Others
17.9.4.3. New Zealand CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By Type
17.9.4.3.1. Flavored
17.9.4.3.2. Unflavored/ Natural
17.9.4.4. New Zealand CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By Strength
17.9.4.4.1. Less than 350 mg
17.9.4.4.2. 350 mg to 750 mg
17.9.4.4.3. 750 mg to 1500 mg
17.9.4.4.4. More than 1500 mg
17.9.4.5. New Zealand CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By Medical Indication
17.9.4.5.1. Anxiety and Depression
17.9.4.5.2. Nausea
17.9.4.5.3. Digestive Disorder
17.9.4.5.4. Chronic Pain
17.9.4.5.5. Infection Prevention
17.9.4.5.6. Sleep Disorders
17.9.4.5.7. Others
17.9.4.6. New Zealand CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By Application
17.9.4.6.1. Humans
17.9.4.6.2. Animals/ Pets
17.9.4.7. New Zealand CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
17.9.4.7.1. Online
17.9.4.7.2. Offline
17.9.4.7.2.1. Retail
Pharmacy
17.9.4.7.2.2. Hospital
Pharmacy
17.9.4.7.2.3. Others
17.9.5. Australia
17.9.5.1. Australia CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts,
By CBD Type
17.9.5.1.1. Full-spectrum CBD (Less than 0.3 Percent THC)
17.9.5.1.2. Broad-spectrum CBD (THC-free)
17.9.5.1.3. CBD Isolate
17.9.5.2. Australia CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts,
By Product Type
17.9.5.2.1. Tinctures
17.9.5.2.2. Drops
17.9.5.2.3. Sprays
17.9.5.2.4. Others
17.9.5.3. Australia CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts,
By Type
17.9.5.3.1. Flavored
17.9.5.3.2. Unflavored/ Natural
17.9.5.4. Australia CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts,
By Strength
17.9.5.4.1. Less than 350 mg
17.9.5.4.2. 350 mg to 750 mg
17.9.5.4.3. 750 mg to 1500 mg
17.9.5.4.4. More than 1500 mg
17.9.5.5. Australia CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts,
By Medical Indication
17.9.5.5.1. Anxiety and Depression
17.9.5.5.2. Nausea
17.9.5.5.3. Digestive Disorder
17.9.5.5.4. Chronic Pain
17.9.5.5.5. Infection Prevention
17.9.5.5.6. Sleep Disorders
17.9.5.5.7. Others
17.9.5.6. Australia CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts,
By Application
17.9.5.6.1. Humans
17.9.5.6.2. Animals/ Pets
17.9.5.7. Australia CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts,
By Distribution Channel
17.9.5.7.1. Online
17.9.5.7.2. Offline
17.9.5.7.2.1. Retail
Pharmacy
17.9.5.7.2.2. Hospital
Pharmacy
17.9.5.7.2.3. Others
17.9.6. South
Korea
17.9.6.1. South Korea CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By CBD Type
17.9.6.1.1. Full-spectrum CBD (Less than 0.3 Percent THC)
17.9.6.1.2. Broad-spectrum CBD (THC-free)
17.9.6.1.3. CBD Isolate
17.9.6.2. South Korea CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By Product Type
17.9.6.2.1. Tinctures
17.9.6.2.2. Drops
17.9.6.2.3. Sprays
17.9.6.2.4. Others
17.9.6.3. South Korea CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By Type
17.9.6.3.1. Flavored
17.9.6.3.2. Unflavored/ Natural
17.9.6.4. South Korea CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By Strength
17.9.6.4.1. Less than 350 mg
17.9.6.4.2. 350 mg to 750 mg
17.9.6.4.3. 750 mg to 1500 mg
17.9.6.4.4. More than 1500 mg
17.9.6.5. South Korea CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By Medical Indication
17.9.6.5.1. Anxiety and Depression
17.9.6.5.2. Nausea
17.9.6.5.3. Digestive Disorder
17.9.6.5.4. Chronic Pain
17.9.6.5.5. Infection Prevention
17.9.6.5.6. Sleep Disorders
17.9.6.5.7. Others
17.9.6.6. South Korea CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By Application
17.9.6.6.1. Humans
17.9.6.6.2. Animals/ Pets
17.9.6.7. South Korea CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
17.9.6.7.1. Online
17.9.6.7.2. Offline
17.9.6.7.2.1. Retail
Pharmacy
17.9.6.7.2.2. Hospital
Pharmacy
17.9.6.7.2.3. Others
17.9.7. Southeast
Asia
17.9.7.1. Southeast Asia CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By CBD Type
17.9.7.1.1. Full-spectrum CBD (Less than 0.3 Percent THC)
17.9.7.1.2. Broad-spectrum CBD (THC-free)
17.9.7.1.3. CBD Isolate
17.9.7.2. Southeast Asia CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By Product Type
17.9.7.2.1. Tinctures
17.9.7.2.2. Drops
17.9.7.2.3. Sprays
17.9.7.2.4. Others
17.9.7.3. Southeast Asia CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts,
By Type
17.9.7.3.1. Flavored
17.9.7.3.2. Unflavored/ Natural
17.9.7.4. Southeast Asia CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By Strength
17.9.7.4.1. Less than 350 mg
17.9.7.4.2. 350 mg to 750 mg
17.9.7.4.3. 750 mg to 1500 mg
17.9.7.4.4. More than 1500 mg
17.9.7.5. Southeast Asia CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts,
By Medical Indication
17.9.7.5.1. Anxiety and Depression
17.9.7.5.2. Nausea
17.9.7.5.3. Digestive Disorder
17.9.7.5.4. Chronic Pain
17.9.7.5.5. Infection Prevention
17.9.7.5.6. Sleep Disorders
17.9.7.5.7. Others
17.9.7.6. Southeast Asia CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By Application
17.9.7.6.1. Humans
17.9.7.6.2. Animals/ Pets
17.9.7.7. Southeast Asia CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
17.9.7.7.1. Online
17.9.7.7.2. Offline
17.9.7.7.2.1. Retail
Pharmacy
17.9.7.7.2.2. Hospital
Pharmacy
17.9.7.7.2.3. Others
17.9.7.8. Southeast Asia CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By Country
17.9.7.8.1. Indonesia
17.9.7.8.2. Thailand
17.9.7.8.3. Malaysia
17.9.7.8.4. Singapore
17.9.7.8.5. Rest of Southeast Asia
17.9.8. Rest of
Asia Pacific
17.9.8.1. Rest of Asia Pacific CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By CBD Type
17.9.8.1.1. Full-spectrum CBD (Less than 0.3 Percent THC)
17.9.8.1.2. Broad-spectrum CBD (THC-free)
17.9.8.1.3. CBD Isolate
17.9.8.2. Rest of Asia Pacific CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By Product Type
17.9.8.2.1. Tinctures
17.9.8.2.2. Drops
17.9.8.2.3. Sprays
17.9.8.2.4. Others
17.9.8.3. Rest of Asia Pacific CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By Type
17.9.8.3.1. Flavored
17.9.8.3.2. Unflavored/ Natural
17.9.8.4. Rest of Asia Pacific CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts,
By Strength
17.9.8.4.1. Less than 350 mg
17.9.8.4.2. 350 mg to 750 mg
17.9.8.4.3. 750 mg to 1500 mg
17.9.8.4.4. More than 1500 mg
17.9.8.5. Rest of Asia Pacific CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By Medical Indication
17.9.8.5.1. Anxiety and Depression
17.9.8.5.2. Nausea
17.9.8.5.3. Digestive Disorder
17.9.8.5.4. Chronic Pain
17.9.8.5.5. Infection Prevention
17.9.8.5.6. Sleep Disorders
17.9.8.5.7. Others
17.9.8.6. Rest of Asia Pacific CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By Application
17.9.8.6.1. Humans
17.9.8.6.2. Animals/ Pets
17.9.8.7. Rest of Asia Pacific CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
17.9.8.7.1. Online
17.9.8.7.2. Offline
17.9.8.7.2.1. Retail
Pharmacy
17.9.8.7.2.2. Hospital
Pharmacy
17.9.8.7.2.3. Others
17.10. Key
Segment for Channeling Investments
17.10.1. By
Country
17.10.2. By CBD
Type
17.10.3. By
Product Type
17.10.4. By
Type
17.10.5. By
Strength
17.10.6. By
Medical Indication
17.10.7. By
Application
17.10.8. By
Distribution Channel
18. Middle East and Africa CBD Hemp Oil Market Analysis and
Forecasts, 2023 - 2031
18.1. Overview
18.1.1. Middle
East and Africa CBD Hemp Oil Market Revenue (US$ Mn)
18.2. Middle
East and Africa CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By CBD Type
18.2.1. Full-spectrum
CBD (Less than 0.3 Percent THC)
18.2.2. Broad-spectrum
CBD (THC-free)
18.2.3. CBD
Isolate
18.3. Middle
East and Africa CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By Product
Type
18.3.1. Tinctures
18.3.2. Drops
18.3.3. Sprays
18.3.4. Others
18.4. Middle
East and Africa CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By Type
18.4.1. Flavored
18.4.2. Unflavored/
Natural
18.5. Middle
East and Africa CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By Strength
18.5.1. Less
than 350 mg
18.5.2. 350 mg
to 750 mg
18.5.3. 750 mg
to 1500 mg
18.5.4. More
than 1500 mg
18.6. Middle
East and Africa CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By Medical
Indication
18.6.1. Anxiety
and Depression
18.6.2. Nausea
18.6.3. Digestive
Disorder
18.6.4. Chronic
Pain
18.6.5. Infection
Prevention
18.6.6. Sleep
Disorders
18.6.7. Others
18.7. Middle
East and Africa CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Application
18.7.1. Humans
18.7.2. Animals/
Pets
18.8. Middle
East and Africa CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
18.8.1. Online
18.8.2. Offline
18.8.2.1. Retail Pharmacy
18.8.2.2. Hospital Pharmacy
18.8.2.3. Others
18.9. Middle
East and Africa CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By Country
18.9.1. Saudi
Arabia
18.9.1.1. Saudi Arabia CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By CBD Type
18.9.1.1.1. Full-spectrum CBD (Less than 0.3 Percent THC)
18.9.1.1.2. Broad-spectrum CBD (THC-free)
18.9.1.1.3. CBD Isolate
18.9.1.2. Saudi Arabia CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By Product Type
18.9.1.2.1. Tinctures
18.9.1.2.2. Drops
18.9.1.2.3. Sprays
18.9.1.2.4. Others
18.9.1.3. Saudi Arabia CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By Type
18.9.1.3.1. Flavored
18.9.1.3.2. Unflavored/ Natural
18.9.1.4. Saudi Arabia CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By Strength
18.9.1.4.1. Less than 350 mg
18.9.1.4.2. 350 mg to 750 mg
18.9.1.4.3. 750 mg to 1500 mg
18.9.1.4.4. More than 1500 mg
18.9.1.5. Saudi Arabia CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By Medical Indication
18.9.1.5.1. Anxiety and Depression
18.9.1.5.2. Nausea
18.9.1.5.3. Digestive Disorder
18.9.1.5.4. Chronic Pain
18.9.1.5.5. Infection Prevention
18.9.1.5.6. Sleep Disorders
18.9.1.5.7. Others
18.9.1.6. Saudi Arabia CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By Application
18.9.1.6.1. Humans
18.9.1.6.2. Animals/ Pets
18.9.1.7. Saudi Arabia CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
18.9.1.7.1. Online
18.9.1.7.2. Offline
18.9.1.7.2.1. Retail
Pharmacy
18.9.1.7.2.2. Hospital
Pharmacy
18.9.1.7.2.3. Others
18.9.2. UAE
18.9.2.1. UAE CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By CBD
Type
18.9.2.1.1. Full-spectrum CBD (Less than 0.3 Percent THC)
18.9.2.1.2. Broad-spectrum CBD (THC-free)
18.9.2.1.3. CBD Isolate
18.9.2.2. UAE CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Product Type
18.9.2.2.1. Tinctures
18.9.2.2.2. Drops
18.9.2.2.3. Sprays
18.9.2.2.4. Others
18.9.2.3. UAE CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Type
18.9.2.3.1. Flavored
18.9.2.3.2. Unflavored/ Natural
18.9.2.4. UAE CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Strength
18.9.2.4.1. Less than 350 mg
18.9.2.4.2. 350 mg to 750 mg
18.9.2.4.3. 750 mg to 1500 mg
18.9.2.4.4. More than 1500 mg
18.9.2.5. UAE CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By Medical
Indication
18.9.2.5.1. Anxiety and Depression
18.9.2.5.2. Nausea
18.9.2.5.3. Digestive Disorder
18.9.2.5.4. Chronic Pain
18.9.2.5.5. Infection Prevention
18.9.2.5.6. Sleep Disorders
18.9.2.5.7. Others
18.9.2.6. UAE CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Application
18.9.2.6.1. Humans
18.9.2.6.2. Animals/ Pets
18.9.2.7. UAE CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
18.9.2.7.1. Online
18.9.2.7.2. Offline
18.9.2.7.2.1. Retail
Pharmacy
18.9.2.7.2.2. Hospital
Pharmacy
18.9.2.7.2.3. Others
18.9.3. Egypt
18.9.3.1. Egypt CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
CBD Type
18.9.3.1.1. Full-spectrum CBD (Less than 0.3 Percent THC)
18.9.3.1.2. Broad-spectrum CBD (THC-free)
18.9.3.1.3. CBD Isolate
18.9.3.2. Egypt CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Product Type
18.9.3.2.1. Tinctures
18.9.3.2.2. Drops
18.9.3.2.3. Sprays
18.9.3.2.4. Others
18.9.3.3. Egypt CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Type
18.9.3.3.1. Flavored
18.9.3.3.2. Unflavored/ Natural
18.9.3.4. Egypt CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Strength
18.9.3.4.1. Less than 350 mg
18.9.3.4.2. 350 mg to 750 mg
18.9.3.4.3. 750 mg to 1500 mg
18.9.3.4.4. More than 1500 mg
18.9.3.5. Egypt CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Medical Indication
18.9.3.5.1. Anxiety and Depression
18.9.3.5.2. Nausea
18.9.3.5.3. Digestive Disorder
18.9.3.5.4. Chronic Pain
18.9.3.5.5. Infection Prevention
18.9.3.5.6. Sleep Disorders
18.9.3.5.7. Others
18.9.3.6. Egypt CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Application
18.9.3.6.1. Humans
18.9.3.6.2. Animals/ Pets
18.9.3.7. Egypt CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
18.9.3.7.1. Online
18.9.3.7.2. Offline
18.9.3.7.2.1. Retail
Pharmacy
18.9.3.7.2.2. Hospital
Pharmacy
18.9.3.7.2.3. Others
18.9.4. Kuwait
18.9.4.1. Kuwait CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
CBD Type
18.9.4.1.1. Full-spectrum CBD (Less than 0.3 Percent THC)
18.9.4.1.2. Broad-spectrum CBD (THC-free)
18.9.4.1.3. CBD Isolate
18.9.4.2. Kuwait CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Product Type
18.9.4.2.1. Tinctures
18.9.4.2.2. Drops
18.9.4.2.3. Sprays
18.9.4.2.4. Others
18.9.4.3. Kuwait CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Type
18.9.4.3.1. Flavored
18.9.4.3.2. Unflavored/ Natural
18.9.4.4. Kuwait CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Strength
18.9.4.4.1. Less than 350 mg
18.9.4.4.2. 350 mg to 750 mg
18.9.4.4.3. 750 mg to 1500 mg
18.9.4.4.4. More than 1500 mg
18.9.4.5. Kuwait CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Medical Indication
18.9.4.5.1. Anxiety and Depression
18.9.4.5.2. Nausea
18.9.4.5.3. Digestive Disorder
18.9.4.5.4. Chronic Pain
18.9.4.5.5. Infection Prevention
18.9.4.5.6. Sleep Disorders
18.9.4.5.7. Others
18.9.4.6. Kuwait CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Application
18.9.4.6.1. Humans
18.9.4.6.2. Animals/ Pets
18.9.4.7. Kuwait CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
18.9.4.7.1. Online
18.9.4.7.2. Offline
18.9.4.7.2.1. Retail
Pharmacy
18.9.4.7.2.2. Hospital
Pharmacy
18.9.4.7.2.3. Others
18.9.5. South
Africa
18.9.5.1. South Africa CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By CBD Type
18.9.5.1.1. Full-spectrum CBD (Less than 0.3 Percent THC)
18.9.5.1.2. Broad-spectrum CBD (THC-free)
18.9.5.1.3. CBD Isolate
18.9.5.2. South Africa CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By Product Type
18.9.5.2.1. Tinctures
18.9.5.2.2. Drops
18.9.5.2.3. Sprays
18.9.5.2.4. Others
18.9.5.3. South Africa CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By Type
18.9.5.3.1. Flavored
18.9.5.3.2. Unflavored/ Natural
18.9.5.4. South Africa CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By Strength
18.9.5.4.1. Less than 350 mg
18.9.5.4.2. 350 mg to 750 mg
18.9.5.4.3. 750 mg to 1500 mg
18.9.5.4.4. More than 1500 mg
18.9.5.5. South Africa CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By Medical Indication
18.9.5.5.1. Anxiety and Depression
18.9.5.5.2. Nausea
18.9.5.5.3. Digestive Disorder
18.9.5.5.4. Chronic Pain
18.9.5.5.5. Infection Prevention
18.9.5.5.6. Sleep Disorders
18.9.5.5.7. Others
18.9.5.6. South Africa CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By Application
18.9.5.6.1. Humans
18.9.5.6.2. Animals/ Pets
18.9.5.7. South Africa CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
18.9.5.7.1. Online
18.9.5.7.2. Offline
18.9.5.7.2.1. Retail
Pharmacy
18.9.5.7.2.2. Hospital
Pharmacy
18.9.5.7.2.3. Others
18.9.6. Rest of
Middle East & Africa
18.9.6.1. Rest of Middle East & Africa CBD Hemp Oil Market Revenue
(US$ Mn) and Forecasts, By CBD Type
18.9.6.1.1. Full-spectrum CBD (Less than 0.3 Percent THC)
18.9.6.1.2. Broad-spectrum CBD (THC-free)
18.9.6.1.3. CBD Isolate
18.9.6.2. Rest of Middle East & Africa CBD Hemp Oil Market Revenue
(US$ Mn) and Forecasts, By Product Type
18.9.6.2.1. Tinctures
18.9.6.2.2. Drops
18.9.6.2.3. Sprays
18.9.6.2.4. Others
18.9.6.3. Rest of Middle East & Africa CBD Hemp Oil Market Revenue
(US$ Mn) and Forecasts, By Type
18.9.6.3.1. Flavored
18.9.6.3.2. Unflavored/ Natural
18.9.6.4. Rest of Middle East & Africa CBD Hemp Oil Market Revenue
(US$ Mn) and Forecasts, By Strength
18.9.6.4.1. Less than 350 mg
18.9.6.4.2. 350 mg to 750 mg
18.9.6.4.3. 750 mg to 1500 mg
18.9.6.4.4. More than 1500 mg
18.9.6.5. Rest of Middle East & Africa CBD Hemp Oil Market Revenue
(US$ Mn) and Forecasts, By Medical Indication
18.9.6.5.1. Anxiety and Depression
18.9.6.5.2. Nausea
18.9.6.5.3. Digestive Disorder
18.9.6.5.4. Chronic Pain
18.9.6.5.5. Infection Prevention
18.9.6.5.6. Sleep Disorders
18.9.6.5.7. Others
18.9.6.6. Rest of Middle East & Africa CBD Hemp Oil Market Revenue
(US$ Mn) and Forecasts, By Application
18.9.6.6.1. Humans
18.9.6.6.2. Animals/ Pets
18.9.6.7. Rest of Middle East & Africa CBD Hemp Oil Market Revenue
(US$ Mn) and Forecasts, By Distribution Channel
18.9.6.7.1. Online
18.9.6.7.2. Offline
18.9.6.7.2.1. Retail
Pharmacy
18.9.6.7.2.2. Hospital
Pharmacy
18.9.6.7.2.3. Others
18.10. Key
Segment for Channeling Investments
18.10.1. By
Country
18.10.2. By CBD
Type
18.10.3. By
Product Type
18.10.4. By
Type
18.10.5. By
Strength
18.10.6. By
Medical Indication
18.10.7. By
Application
18.10.8. By
Distribution Channel
19. Latin America CBD Hemp Oil Market Analysis and Forecasts, 2023
- 2031
19.1. Overview
19.1.1. Latin
America CBD Hemp Oil Market Revenue (US$ Mn)
19.2. Latin
America CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By CBD Type
19.2.1. Full-spectrum
CBD (Less than 0.3 Percent THC)
19.2.2. Broad-spectrum
CBD (THC-free)
19.2.3. CBD
Isolate
19.3. Latin
America CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By Product Type
19.3.1. Tinctures
19.3.2. Drops
19.3.3. Sprays
19.3.4. Others
19.4. Latin
America CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By Type
19.4.1. Flavored
19.4.2. Unflavored/
Natural
19.5. Latin
America CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By Strength
19.5.1. Less
than 350 mg
19.5.2. 350 mg
to 750 mg
19.5.3. 750 mg
to 1500 mg
19.5.4. More
than 1500 mg
19.6. Latin
America CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By Medical
Indication
19.6.1. Anxiety
and Depression
19.6.2. Nausea
19.6.3. Digestive
Disorder
19.6.4. Chronic
Pain
19.6.5. Infection
Prevention
19.6.6. Sleep
Disorders
19.6.7. Others
19.7. Latin
America CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By Application
19.7.1. Humans
19.7.2. Animals/
Pets
19.8. Latin
America CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
19.8.1. Online
19.8.2. Offline
19.8.2.1. Retail Pharmacy
19.8.2.2. Hospital Pharmacy
19.8.2.3. Others
19.9. Latin
America CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By Country
19.9.1. Brazil
19.9.1.1. Brazil CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
CBD Type
19.9.1.1.1. Full-spectrum CBD (Less than 0.3 Percent THC)
19.9.1.1.2. Broad-spectrum CBD (THC-free)
19.9.1.1.3. CBD Isolate
19.9.1.2. Brazil CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Product Type
19.9.1.2.1. Tinctures
19.9.1.2.2. Drops
19.9.1.2.3. Sprays
19.9.1.2.4. Others
19.9.1.3. Brazil CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Type
19.9.1.3.1. Flavored
19.9.1.3.2. Unflavored/ Natural
19.9.1.4. Brazil CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Strength
19.9.1.4.1. Less than 350 mg
19.9.1.4.2. 350 mg to 750 mg
19.9.1.4.3. 750 mg to 1500 mg
19.9.1.4.4. More than 1500 mg
19.9.1.5. Brazil CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Medical Indication
19.9.1.5.1. Anxiety and Depression
19.9.1.5.2. Nausea
19.9.1.5.3. Digestive Disorder
19.9.1.5.4. Chronic Pain
19.9.1.5.5. Infection Prevention
19.9.1.5.6. Sleep Disorders
19.9.1.5.7. Others
19.9.1.6. Brazil CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Application
19.9.1.6.1. Humans
19.9.1.6.2. Animals/ Pets
19.9.1.7. Brazil CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
19.9.1.7.1. Online
19.9.1.7.2. Offline
19.9.1.7.2.1. Retail
Pharmacy
19.9.1.7.2.2. Hospital
Pharmacy
19.9.1.7.2.3. Others
19.9.2. Argentina
19.9.2.1. Argentina CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts,
By CBD Type
19.9.2.1.1. Full-spectrum CBD (Less than 0.3 Percent THC)
19.9.2.1.2. Broad-spectrum CBD (THC-free)
19.9.2.1.3. CBD Isolate
19.9.2.2. Argentina CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts,
By Product Type
19.9.2.2.1. Tinctures
19.9.2.2.2. Drops
19.9.2.2.3. Sprays
19.9.2.2.4. Others
19.9.2.3. Argentina CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts,
By Type
19.9.2.3.1. Flavored
19.9.2.3.2. Unflavored/ Natural
19.9.2.4. Argentina CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts,
By Strength
19.9.2.4.1. Less than 350 mg
19.9.2.4.2. 350 mg to 750 mg
19.9.2.4.3. 750 mg to 1500 mg
19.9.2.4.4. More than 1500 mg
19.9.2.5. Argentina CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts,
By Medical Indication
19.9.2.5.1. Anxiety and Depression
19.9.2.5.2. Nausea
19.9.2.5.3. Digestive Disorder
19.9.2.5.4. Chronic Pain
19.9.2.5.5. Infection Prevention
19.9.2.5.6. Sleep Disorders
19.9.2.5.7. Others
19.9.2.6. Argentina CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts,
By Application
19.9.2.6.1. Humans
19.9.2.6.2. Animals/ Pets
19.9.2.7. Argentina CBD Hemp Oil Market Revenue (US$ Mn) and Forecasts,
By Distribution Channel
19.9.2.7.1. Online
19.9.2.7.2. Offline
19.9.2.7.2.1. Retail
Pharmacy
19.9.2.7.2.2. Hospital
Pharmacy
19.9.2.7.2.3. Others
19.9.3. Rest of
Latin America
19.9.3.1. Rest of Latin America CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By CBD Type
19.9.3.1.1. Full-spectrum CBD (Less than 0.3 Percent THC)
19.9.3.1.2. Broad-spectrum CBD (THC-free)
19.9.3.1.3. CBD Isolate
19.9.3.2. Rest of Latin America CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By Product Type
19.9.3.2.1. Tinctures
19.9.3.2.2. Drops
19.9.3.2.3. Sprays
19.9.3.2.4. Others
19.9.3.3. Rest of Latin America CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By Type
19.9.3.3.1. Flavored
19.9.3.3.2. Unflavored/ Natural
19.9.3.4. Rest of Latin America CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By Strength
19.9.3.4.1. Less than 350 mg
19.9.3.4.2. 350 mg to 750 mg
19.9.3.4.3. 750 mg to 1500 mg
19.9.3.4.4. More than 1500 mg
19.9.3.5. Rest of Latin America CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By Medical Indication
19.9.3.5.1. Anxiety and Depression
19.9.3.5.2. Nausea
19.9.3.5.3. Digestive Disorder
19.9.3.5.4. Chronic Pain
19.9.3.5.5. Infection Prevention
19.9.3.5.6. Sleep Disorders
19.9.3.5.7. Others
19.9.3.6. Rest of Latin America CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By Application
19.9.3.6.1. Humans
19.9.3.6.2. Animals/ Pets
19.9.3.7. Rest of Latin America CBD Hemp Oil Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
19.9.3.7.1. Online
19.9.3.7.2. Offline
19.9.3.7.2.1. Retail
Pharmacy
19.9.3.7.2.2. Hospital
Pharmacy
19.9.3.7.2.3. Others
19.10. Key
Segment for Channeling Investments
19.10.1. By
Country
19.10.2. By CBD
Type
19.10.3. By
Product Type
19.10.4. By
Type
19.10.5. By
Strength
19.10.6. By
Medical Indication
19.10.7. By
Application
19.10.8. By
Distribution Channel
20. Competitive Benchmarking
20.1. Brand
Benchmarking
20.2. Market
Share Analysis, 2022
20.3. Global
Presence and Growth Strategies
20.3.1. Mergers
and Acquisitions
20.3.2. Product
Launches
20.3.3. Investments
Trends
20.3.4. R&D
Initiatives
21. Player Profiles
21.1. 4 Corners
Cannabis
21.1.1. Company
Details
21.1.2. Company
Overview
21.1.3. Product
Offerings
21.1.4. Key
Developments
21.1.5. Financial
Analysis
21.1.6. SWOT
Analysis
21.1.7. Business
Strategies
21.2. Absolute Nature Inc
21.2.1. Company
Details
21.2.2. Company
Overview
21.2.3. Product
Offerings
21.2.4. Key
Developments
21.2.5. Financial
Analysis
21.2.6. SWOT
Analysis
21.2.7. Business
Strategies
21.3. CBDistillery
21.3.1. Company
Details
21.3.2. Company
Overview
21.3.3. Product
Offerings
21.3.4. Key
Developments
21.3.5. Financial
Analysis
21.3.6. SWOT
Analysis
21.3.7. Business
Strategies
21.4. CHARLOTTE’S WEB
21.4.1. Company
Details
21.4.2. Company
Overview
21.4.3. Product
Offerings
21.4.4. Key
Developments
21.4.5. Financial
Analysis
21.4.6. SWOT
Analysis
21.4.7. Business
Strategies
21.5. Cheef Botanicals
21.5.1. Company
Details
21.5.2. Company
Overview
21.5.3. Product
Offerings
21.5.4. Key
Developments
21.5.5. Financial
Analysis
21.5.6. SWOT
Analysis
21.5.7. Business
Strategies
21.6. CV Sciences, Inc
21.6.1. Company
Details
21.6.2. Company
Overview
21.6.3. Product
Offerings
21.6.4. Key
Developments
21.6.5. Financial
Analysis
21.6.6. SWOT
Analysis
21.6.7. Business
Strategies
21.7. Holmes Organics
21.7.1. Company
Details
21.7.2. Company
Overview
21.7.3. Product
Offerings
21.7.4. Key
Developments
21.7.5. Financial
Analysis
21.7.6. SWOT
Analysis
21.7.7. Business
Strategies
21.8. Lazarus Naturals
21.8.1. Company
Details
21.8.2. Company
Overview
21.8.3. Product
Offerings
21.8.4. Key
Developments
21.8.5. Financial
Analysis
21.8.6. SWOT
Analysis
21.8.7. Business
Strategies
21.9. NuLeaf Naturals, LLC
21.9.1. Company
Details
21.9.2. Company
Overview
21.9.3. Product
Offerings
21.9.4. Key
Developments
21.9.5. Financial
Analysis
21.9.6. SWOT
Analysis
21.9.7. Business
Strategies
21.10. Premium Jane
21.10.1. Company
Details
21.10.2. Company
Overview
21.10.3. Product
Offerings
21.10.4. Key
Developments
21.10.5. Financial
Analysis
21.10.6. SWOT
Analysis
21.10.7. Business
Strategies
21.11. Social CBD
21.11.1. Company
Details
21.11.2. Company
Overview
21.11.3. Product
Offerings
21.11.4. Key
Developments
21.11.5. Financial
Analysis
21.11.6. SWOT
Analysis
21.11.7. Business
Strategies
21.12. Veritas Farms.
21.12.1.
Company Details
21.12.2.
Company Overview
21.12.3.
Product Offerings
21.12.4.
Key Developments
21.12.5.
Financial Analysis
21.12.6.
SWOT Analysis
21.12.7.
Business Strategies
21.13. ZATURAL
21.13.1.
Company Details
21.13.2.
Company Overview
21.13.3.
Product Offerings
21.13.4.
Key Developments
21.13.5.
Financial Analysis
21.13.6.
SWOT Analysis
21.13.7.
Business Strategies
21.14. Other
Market Participants
22. Key Findings
Note: This ToC is tentative
and can be changed according to the research study conducted during the course
of report completion.
**Exclusive for Multi-User
and Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
